{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T18:57:17Z","timestamp":1774119437556,"version":"3.50.1"},"reference-count":92,"publisher":"Public Library of Science (PLoS)","issue":"5","license":[{"start":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T00:00:00Z","timestamp":1211932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0002291","type":"journal-article","created":{"date-parts":[[2008,5,28]],"date-time":"2008-05-28T02:51:24Z","timestamp":1211943084000},"page":"e2291","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":36,"title":["Why Are Clinicians Not Embracing the Results from Pivotal Clinical Trials in Severe Sepsis? A Bayesian Analysis"],"prefix":"10.1371","volume":"3","author":[{"given":"Andre C.","family":"Kalil","sequence":"first","affiliation":[]},{"given":"Junfeng","family":"Sun","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2008,5,28]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1164\/rccm.200204-302OC","article-title":"Risk and the efficacy of antiinflammatory agents: retrospective and confirmatory studies of sepsis.","volume":"166","author":"PQ Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJMoa010307","article-title":"Early goal-directed therapy in the treatment of severe sepsis and septic shock.","volume":"345","author":"E Rivers","year":"2001","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","article-title":"Efficacy and safety of recombinant human activated protein C for severe sepsis.","volume":"344","author":"GR Bernard","year":"2001","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1001\/jama.288.7.862","article-title":"Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock.","volume":"288","author":"D Annane","year":"2002","journal-title":"Jama"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM200005043421801","article-title":"Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network.","volume":"342","year":"2000","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1056\/NEJMoa011300","article-title":"Intensive insulin therapy in the critically ill patients.","volume":"345","author":"G van den Berghe","year":"2001","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1097\/01.CCM.0000117317.18092.E4","article-title":"Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.","volume":"32","author":"RP Dellinger","year":"2004","journal-title":"Crit Care Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1056\/NEJMp068197","article-title":"Surviving sepsis\u2013practice guidelines, marketing campaigns, and Eli Lilly.","volume":"355","author":"PQ Eichacker","year":"2006","journal-title":"N Engl J Med"},{"key":"ref9","first-page":"295","article-title":"Publication of study results does not increase use of lung-protective strategy in patients with acute lung injury.","author":"GD Rubenfeld","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1164\/rccm.200208-956OC","article-title":"Meta-analysis of acute lung injury and acute respiratory distress syndrome trials testing low tidal volumes.","volume":"166","author":"PQ Eichacker","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1164\/rccm.2303003","article-title":"Are we really reducing tidal volume\u2013and should we?","volume":"167","author":"JD Ricard","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/01.CCM.0000162384.71993.A3","article-title":"Mechanical ventilation in ARDS: One size does not fit all.","volume":"33","author":"KJ Deans","year":"2005","journal-title":"Crit Care Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1186\/cc5022","article-title":"Drotrecogin alfa (activated): down and not out, but not really in either.","volume":"10","author":"JO Friedrich","year":"2006","journal-title":"Crit Care"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1007\/s00134-006-0086-9","article-title":"When a single pivotal trial should not be enough-the case of drotrecogin-alfa (activated).","volume":"32","author":"CJ Wiedermann","year":"2006","journal-title":"Intensive Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00134-005-2829-4","article-title":"Activated protein C: do more survive?","volume":"31","author":"AF Mackenzie","year":"2005","journal-title":"Intensive Care Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1097\/01.CCM.0000183002.26587.FF","article-title":"Reassessing recombinant human activated protein C for sepsis: time for a new randomized controlled trial.","volume":"33","author":"PQ Eichacker","year":"2005","journal-title":"Crit Care Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/cc4918","article-title":"The incidence and outcome of septic shock patients in the absence of early-goal directed therapy.","volume":"10","author":"BC Ho","year":"2006","journal-title":"Crit Care"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jcrc.2005.05.007","article-title":"Struggle for implementation of new strategies in intensive care medicine: anticoagulation, insulin, and lower tidal volumes.","volume":"20","author":"MJ Schultz","year":"2005","journal-title":"J Crit Care"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1097\/01.CCM.0000194536.89694.06","article-title":"Predisposing factors for hypoglycemia in the intensive care unit.","volume":"34","author":"TM Vriesendorp","year":"2006","journal-title":"Crit Care Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","article-title":"Measurements of serum free cortisol in critically ill patients.","volume":"350","author":"AH Hamrahian","year":"2004","journal-title":"N Engl J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"90","DOI":"10.7326\/ACPJC-2002-136-3-090","article-title":"Early goal-directed therapy reduced mortality and multiorgan dysfunction in severe sepsis or septic shock.","volume":"136","author":"C Natanson","year":"2002","journal-title":"ACP J Club"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM200203283461314","article-title":"Goal-directed therapy for severe sepsis.","volume":"346","author":"PE Marik","year":"2002","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM200203283461314","article-title":"Goal-directed therapy for severe sepsis.","volume":"346","author":"F Abroug","year":"2002","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM200203283461314","article-title":"Goal-directed therapy for severe sepsis.","volume":"346","author":"S Sarkar","year":"2002","journal-title":"N Engl J Med"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJMsb020574","article-title":"Risks and benefits of activated protein C treatment for severe sepsis.","volume":"347","author":"HS Warren","year":"2002","journal-title":"N Engl J Med"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1007\/s00508-005-0396-x","article-title":"Bioethics, the Surviving Sepsis Campaign, and the industry.","volume":"117","author":"CJ Wiedermann","year":"2005","journal-title":"Wien Klin Wochenschr"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1164\/rccm.2307001","article-title":"The role of a journal in a scientific controversy.","volume":"168","author":"MJ Tobin","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/jama.1995.03520350053028","article-title":"Placing trials in context using Bayesian analysis. GUSTO revisited by Reverend Bayes.","volume":"273","author":"JM Brophy","year":"1995","journal-title":"Jama"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/jama.292.1.89","article-title":"Efficacy and bleeding complications among patients randomized to enoxaparin or unfractionated heparin for antithrombin therapy in non-ST-Segment elevation acute coronary syndromes: a systematic overview.","volume":"292","author":"JL Petersen","year":"2004","journal-title":"Jama"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.7326\/0003-4819-130-12-199906150-00019","article-title":"Toward evidence-based medical statistics. 2: The Bayes factor.","volume":"130","author":"SN Goodman","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.7326\/0003-4819-130-12-199906150-00022","article-title":"Standing statistics right side up.","volume":"130","author":"F Davidoff","year":"1999","journal-title":"Ann Intern Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/jech.52.5.318","article-title":"Clinical significance not statistical significance: a simple Bayesian alternative to p values.","volume":"52","author":"PR Burton","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1136\/bmj.322.7280.226","article-title":"Sifting the evidence-what's wrong with significance tests?","volume":"322","author":"JA Sterne","year":"2001","journal-title":"Bmj"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/jama.1987.03390180077027","article-title":"Are all significant P values created equal? The analogy between diagnostic tests and clinical research.","volume":"257","author":"WS Browner","year":"1987","journal-title":"Jama"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1191\/1740774505cn098oa","article-title":"Introduction to Bayesian methods I: measuring the strength of evidence.","volume":"2","author":"SN Goodman","year":"2005","journal-title":"Clin Trials"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1136\/bmj.330.7499.1080","article-title":"Why clinicians are natural bayesians.","volume":"330","author":"CJ Gill","year":"2005","journal-title":"Bmj"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrd1927","article-title":"Bayesian clinical trials.","volume":"5","author":"DA Berry","year":"2006","journal-title":"Nat Rev Drug Discov"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1016\/j.jacc.2004.01.035","article-title":"Prior convictions: Bayesian approaches to the analysis and interpretation of clinical megatrials.","volume":"43","author":"GA Diamond","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1017\/S0266462301104034","article-title":"Using full probability models to compute probabilities of actual interest to decision makers.","volume":"17","author":"FE Harrell Jr","year":"2001","journal-title":"Int J Technol Assess Health Care"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/01.shk.0000232271.09440.8f","article-title":"A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial.","volume":"26","author":"SM Lin","year":"2006","journal-title":"Shock"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1378\/chest.115.2.453","article-title":"A randomized and controlled trial of the effect of treatment aimed at maximizing oxygen delivery in patients with severe sepsis or septic shock.","volume":"115","author":"I Alia","year":"1999","journal-title":"Chest"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1097\/00003246-199806000-00018","article-title":"Relationship of mortality to increasing oxygen delivery in patients > or = 50 years of age: a prospective, randomized trial.","volume":"26","author":"M Yu","year":"1998","journal-title":"Crit Care Med"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1097\/00003246-199306000-00009","article-title":"Effect of maximizing oxygen delivery on morbidity and mortality rates in critically ill patients: a prospective, randomized, controlled study.","volume":"21","author":"M Yu","year":"1993","journal-title":"Crit Care Med"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1378\/chest.102.1.216","article-title":"Elevation of cardiac output and oxygen delivery improves outcome in septic shock.","volume":"102","author":"J Tuchschmidt","year":"1992","journal-title":"Chest"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJM199406163302404","article-title":"Elevation of systemic oxygen delivery in the treatment of critically ill patients.","volume":"330","author":"MA Hayes","year":"1994","journal-title":"N Engl J Med"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1056\/NEJM199510193331601","article-title":"A trial of goal-oriented hemodynamic therapy in critically ill patients. SvO2 Collaborative Group.","volume":"333","author":"L Gattinoni","year":"1995","journal-title":"N Engl J Med"},{"key":"ref47","first-page":"661","article-title":"Efficacy of goal-directed thearpy in the treatment of septic shock.","volume":"18","author":"W Xiao-zhi","year":"2007","journal-title":"Chin Crit Care Med (Engl)"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1097\/00003246-200111000-00003","article-title":"Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis.","volume":"29","author":"GR Bernard","year":"2001","journal-title":"Crit Care Med"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1056\/NEJMoa050935","article-title":"Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death.","volume":"353","author":"E Abraham","year":"2005","journal-title":"N Engl J Med"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1378\/chest.125.6.2206","article-title":"Extended evaluation of recombinant human activated protein C United States Trial (ENHANCE US): a single-arm, phase 3B, multicenter study of drotrecogin alfa (activated) in severe sepsis.","volume":"125","author":"GR Bernard","year":"2004","journal-title":"Chest"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1542\/peds.113.1.7","article-title":"Safety, pharmacokinetics, and pharmacodynamics of drotrecogin alfa (activated) in children with severe sepsis.","volume":"113","author":"P Barton","year":"2004","journal-title":"Pediatrics"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(07)60411-5","article-title":"Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial.","volume":"369","author":"S Nadel","year":"2007","journal-title":"Lancet"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.PCC.0000217470.68764.36","article-title":"ENHANCE: results of a global open-label trial of drotrecogin alfa (activated) in children with severe sepsis.","volume":"7","author":"B Goldstein","year":"2006","journal-title":"Pediatr Crit Care Med"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1001\/jama.1963.63700060029012","article-title":"The effectiveness of hydrocortisone in the management of severe infection.","volume":"183","author":"IL Bennett","year":"1963","journal-title":"JAMA"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"A controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock.","volume":"317","author":"RC Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1097\/00003246-199904000-00025","article-title":"Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study.","volume":"27","author":"J Briegel","year":"1999","journal-title":"Crit Care Med"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/00003246-199804000-00010","article-title":"Reversal of late septic shock with supraphysiologic doses of hydrocortisone.","volume":"26","author":"PE Bollaert","year":"1998","journal-title":"Crit Care Med"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1164\/ajrccm\/138.1.62","article-title":"Ineffectiveness of high-dose methylprednisolone in preventing parenchymal lung injury and improving mortality in patients with septic shock.","volume":"138","author":"JM Luce","year":"1988","journal-title":"Am Rev Respir Dis"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1001\/archsurg.1984.01390170037008","article-title":"The cardiopulmonary response to massive doses of steroids in patients with septic shock.","volume":"119","author":"CE Lucas","year":"1984","journal-title":"Arch Surg"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJM197106032842206","article-title":"Effectiveness of betamethasone in management of severe infections. A double-blind study.","volume":"284","author":"J Klastersky","year":"1971","journal-title":"N Engl J Med"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/00000658-197609000-00011","article-title":"Steroids in the treatment of clinical septic shock.","volume":"184","author":"W Schumer","year":"1976","journal-title":"Ann Surg"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1056\/NEJM198411013111801","article-title":"The effects of high-dose corticosteroids in patients with septic shock. A prospective, controlled study.","volume":"311","author":"CL Sprung","year":"1984","journal-title":"N Engl J Med"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1056\/NEJM198709103171102","article-title":"Effect of high-dose glucocorticoid therapy on mortality in patients with clinical signs of systemic sepsis. The Veterans Administration Systemic Sepsis Cooperative Study Group.","volume":"317","year":"1987","journal-title":"N Engl J Med"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1186\/cc1498","article-title":"Physiological-dose steroid therapy in sepsis [ISRCTN36253388].","volume":"6","author":"O Yildiz","year":"2002","journal-title":"Crit Care"},{"key":"ref65","first-page":"258A","article-title":"Inefficacy of glucocorticoids in shock (double-blind study) [Abstract].","volume":"6","author":"WL Thompson","year":"1976","journal-title":"Clin Res"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa071366","article-title":"Hydrocortisone therapy for patients with septic shock.","volume":"358","author":"CL Sprung","year":"2008","journal-title":"N Engl J Med"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1186\/cc5696","article-title":"Effect of mode of hydrocortisone administration on glycemic control in patients with septic shock: a prospective randomized trial.","volume":"11","author":"P Loisa","year":"2007","journal-title":"Crit Care"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJM199802053380602","article-title":"Effect of a protective-ventilation strategy on mortality in the acute respiratory distress syndrome.","volume":"338","author":"MB Amato","year":"1998","journal-title":"N Engl J Med"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1097\/00003246-199908000-00015","article-title":"Prospective, randomized, controlled clinical trial comparing traditional versus reduced tidal volume ventilation in acute respiratory distress syndrome patients.","volume":"27","author":"RG Brower","year":"1999","journal-title":"Crit Care Med"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1164\/ajrccm.158.6.9801044","article-title":"Tidal volume reduction for prevention of ventilator-induced lung injury in acute respiratory distress syndrome. The Multicenter Trail Group on Tidal Volume reduction in ARDS.","volume":"158","author":"L Brochard","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1056\/NEJM199802053380603","article-title":"Evaluation of a ventilation strategy to prevent barotrauma in patients at high risk for acute respiratory distress syndrome. Pressure- and Volume-Limited Ventilation Strategy Group.","volume":"338","author":"TE Stewart","year":"1998","journal-title":"N Engl J Med"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1164\/rccm.2105050","article-title":"ARDSNet lower tidal volume ventilatory strategy may generate intrinsic positive end-expiratory pressure in patients with acute respiratory distress syndrome.","volume":"165","author":"G de Durante","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"ref73","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.CCM.0000215598.84885.01","article-title":"A high positive end-expiratory pressure, low tidal volume ventilatory strategy improves outcome in persistent acute respiratory distress syndrome: a randomized, controlled trial.","volume":"34","author":"J Villar","year":"2006","journal-title":"Crit Care Med"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa032193","article-title":"Higher versus lower positive end-expiratory pressures in patients with the acute respiratory distress syndrome.","volume":"351","author":"RG Brower","year":"2004","journal-title":"N Engl J Med"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa052521","article-title":"Intensive insulin therapy in the medical ICU.","volume":"354","author":"G Van den Berghe","year":"2006","journal-title":"N Engl J Med"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa070716","article-title":"Intensive insulin therapy and pentastarch resuscitation in severe sepsis.","volume":"358","author":"FM Brunkhorst","year":"2008","journal-title":"N Engl J Med"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.2337\/dc05-2353","article-title":"Intensive insulin therapy in the intensive care unit: assessment by continuous glucose monitoring.","volume":"29","author":"C De Block","year":"2006","journal-title":"Diabetes Care"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1097\/01.CCM.0000248906.10399.CF","article-title":"Evaluation of an intensive insulin protocol for septic patients in a medical intensive care unit.","volume":"34","author":"SB Clayton","year":"2006","journal-title":"Crit Care Med"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"e456","DOI":"10.1371\/journal.pmed.0030456","article-title":"Intensive insulin therapy in intensive care: an example of the struggle to implement evidence-based medicine.","volume":"3","author":"MJ Schultz","year":"2006","journal-title":"PLoS Med"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/01.CCM.0000045568.12881.10","article-title":"Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control.","volume":"31","author":"G Van den Berghe","year":"2003","journal-title":"Crit Care Med"},{"key":"ref81","first-page":"43","article-title":"[Glycemic control in sepsis and septic shock : Friend or foe?].","volume":"57","author":"B Ellger","year":"2008","journal-title":"Anaesthesist"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00134-006-0135-4","article-title":"Management of blood glucose in the critically ill in Australia and New Zealand: a practice survey and inception cohort study.","volume":"32","author":"I Mitchell","year":"2006","journal-title":"Intensive Care Med"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s00134-007-0543-0","article-title":"Failure to achieve glycemic control despite intensive insulin therapy in a medical ICU: incidence and influence on ICU mortality.","volume":"33","author":"JC Lacherade","year":"2007","journal-title":"Intensive Care Med"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1097\/TA.0b013e318047b7dc","article-title":"Morbidity reduction in critically ill trauma patients through use of a computerized insulin infusion protocol: a preliminary study.","volume":"62","author":"EA Toschlog","year":"2007","journal-title":"J Trauma"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-146-4-200702200-00002","article-title":"Intensive intraoperative insulin therapy versus conventional glucose management during cardiac surgery: a randomized trial.","volume":"146","author":"GY Gandhi","year":"2007","journal-title":"Ann Intern Med"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/ije\/dyi312","article-title":"Bayesian perspectives for epidemiological research: I. Foundations and basic methods.","volume":"35","author":"S Greenland","year":"2006","journal-title":"Int J Epidemiol"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1136\/bmj.319.7208.508","article-title":"Methods in health service research. An introduction to bayesian methods in health technology assessment.","volume":"319","author":"DJ Spiegelhalter","year":"1999","journal-title":"Bmj"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta4380","article-title":"Bayesian methods in health technology assessment: a review.","volume":"4","author":"DJ Spiegelhalter","year":"2000","journal-title":"Health Technol Assess"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1056\/NEJMc052759","article-title":"Drotrecogin alfa (activated) in severe sepsis.","volume":"354","author":"SP LaRosa","year":"2006","journal-title":"N Engl J Med"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1097\/01.CCM.0000063445.91548.20","article-title":"Time for a consensus definition of corticosteroid insufficiency in critically ill patients.","volume":"31","author":"D Annane","year":"2003","journal-title":"Crit Care Med"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1097\/01.CCM.0000185641.87051.7C","article-title":"Relative adrenal insufficiency in patients with septic shock: comparison of low-dose and conventional corticotropin tests.","volume":"33","author":"V Siraux","year":"2005","journal-title":"Crit Care Med"},{"key":"ref92","first-page":"295","article-title":"The Environment and Disease: Association or Causation?","volume":"58","author":"AB Hill","year":"1965","journal-title":"Proc R Soc Med"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0002291","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T12:46:46Z","timestamp":1738241206000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0002291"}},"subtitle":[],"editor":[{"given":"Adam J.","family":"Ratner","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2008,5,28]]},"references-count":92,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2008,5,28]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0002291","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,5,28]]}}}